US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Target Atlas in Breast Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Breast Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Ovarian Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Ovarian Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Target Atlas in Endometrial Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Endometrial Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Breast Cancer: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ...  |  read more...
USD 14,250
Target Atlas in Fallopian Tube Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... the most promising Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Fallopian Tube Cancer: A Competitive Outlook" is a one-of-a-kind, ...  |  read more...
USD 6,750
Ovarian Cancer: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ...  |  read more...
USD 14,250
Breast Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 377 drug targets that are included in this drug-pathway analyzing tool. No less than 358 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Ovarian Cancer Drug Pathway Analyzer
8/9/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 291 drug targets that are included in this drug-pathway analyzing tool. No less than 275 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Dysmenorrhea-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Hot Flashes-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Labor And Delivery-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Premenstrual Syndrome-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Uterine Fibroids-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Breast Cancer Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... metastatic setting, the overall survival remains below five years. There are today 636 companies plus partners developing 706 drugs targeting breast cancer in development. In addition, there are 7 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
Breast Biopsy Device Market Analysis By Test Type (Needle Breast Biopsy: Fine-Needle Aspiration, Core-Needle Biopsy, Vacuum-Assisted Core Biopsy; Open Surgical Biopsy: Incisional Breast Biopsy), By Product (Biopsy Needles, Biopsy Tables, Localization Wire
8/8/2016 | published by: Grand View Research
... By Guidance Type (Ultrasound-Guided, Mammography-Guided Stereotactic, Magnetic Resonance-Guided), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024 The breast biopsy device market is expected to reach USD ...  |  read more...
USD 4,700
Global and Chinese Artificial Insemination Catheter Industry, 2016 Market Research Report
8/1/2016 | published by: Prof-Research
... the Chinese market. The report provides key statistics on the market status of the Artificial Insemination Catheter manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, ...  |  read more...
USD 2,900
Vasomotor Symptoms of Menopause-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Vulvar Cancer-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Bacterial Vaginosis-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Epithelial Ovarian Cancer-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Post Menopausal Disorder-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
In Vitro Fertilization Market by Product (Incubators, Cryosystem, Sperm Seperation System, Cryopreservation Media, Embryo Culture Media), Technology (Pre-Implantation Genetic Diagnosis, Intra-Cytoplasmic Sperm Injection) & End Users - Forecast to 2021
7/27/2016 | published by: MarketsandMarkets
... market is expected to reach USD 756.7 million by 2021 from USD 468.3 million in 2016, at a CAGR of 10.1%. Factors such as declining fertility rates, growth in the media age of first-time motherhood, ...  |  read more...
USD 5,650
Post Menopausal Osteoporosis-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2021 - Global Analysis
7/19/2016 | published by: iGate Research PVT LTD.
... world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer. Breast cancer screening is the regular examination of a woman's breasts to find breast cancer early. Screening ...  |  read more...
USD 1,850
< prev 1    3  4  5  6  7  8  9  10